Literature DB >> 27816750

Retinopathy of Prematurity: Intravitreal injections of bevacizumab: timing, technique, and outcomes.

Helen A Mintz-Hittner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27816750     DOI： 10.1016/j.jaapos.2016.10.002

Source DB:  PubMed          Journal:  J AAPOS        ISSN： 1091-8531            Impact factor:   1.220


× No keyword cloud information.
  2 in total

1.  A Quantitative Severity Scale for Retinopathy of Prematurity Using Deep Learning to Monitor Disease Regression After Treatment.

Authors:  Kishan Gupta; J Peter Campbell; Stanford Taylor; James M Brown; Susan Ostmo; R V Paul Chan; Jennifer Dy; Deniz Erdogmus; Stratis Ioannidis; Jayashree Kalpathy-Cramer; Sang J Kim; Michael F Chiang
Journal:  JAMA Ophthalmol       Date:  2019-07-03       Impact factor: 7.389

2.  The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity.

Authors:  Ayşegül Çömez; Yalçın Karaküçük; Mehmet Cüneyt Özmen; Pelin Çelemler; Oğuzhan Saygılı
Journal:  Eye (Lond)       Date:  2021-01-29       Impact factor: 3.775
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.